Spots Global Cancer Trial Database for immunohistochemistry staining method
Every month we try and update this database with for immunohistochemistry staining method cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | NCT00736450 | Contiguous Stag... Noncontiguous S... Stage I Adult D... Stage III Adult... Stage IV Adult ... | oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... vincristine sul... prednisone biopsy microarray anal... immunohistochem... gene expression... cytogenetic ana... | 19 Years - | University of Nebraska | |
| Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate | NCT00459407 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... | defined green t... placebo immunohistochem... immunoenzyme te... laboratory biom... biopsy mass spectromet... high performanc... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | NCT00389922 | Unspecified Adu... | lapatinib ditos... vinorelbine dit... comparative gen... cytogenetic ana... gene expression... mutation analys... polymerase chai... polymorphism an... proteomic profi... reverse transcr... immunohistochem... laboratory biom... lapatinib ditos... Vinorelbine dit... | 18 Years - | University of California, Davis | |
| Biomarkers in Samples From Young Patients With Neuroblastoma | NCT01358604 | Neuroblastoma | polymerase chai... protein express... western blottin... flow cytometry immunohistochem... laboratory biom... | - 120 Years | Children's Oncology Group | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma | NCT00514085 | Melanoma (Skin) | recombinant hum... immunohistochem... laboratory biom... pharmacological... | 18 Years - | Canadian Cancer Trials Group | |
| Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | NCT00550784 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | filgrastim cisplatin cyclophosphamid... melphalan paclitaxel topotecan hydro... TdT-mediated dU... gene expression... immunohistochem... pharmacological... peripheral bloo... | - 60 Years | City of Hope Medical Center | |
| Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer | NCT01231399 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Esoph... Recurrent Gastr... Stage IV Esopha... Stage IV Gastri... | fluorouracil leucovorin calc... oxaliplatin everolimus laboratory biom... immunohistochem... microarray anal... | 19 Years - | City of Hope Medical Center | |
| AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors | NCT00372736 | Unspecified Adu... | AEG35156 docetaxel protein express... reverse transcr... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | Canadian Cancer Trials Group | |
| Laser Spectroscopy of Breast Tissue Through a Needle Device | NCT00918788 | Breast Cancer | biologic sample... immunohistochem... light microscop... medical chart r... histopathologic... needle biopsy spectroscopy | - | Case Comprehensive Cancer Center | |
| Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00589056 | Lung Cancer | cisplatin etoposide nelfinavir mesy... protein express... immunohistochem... laboratory biom... biopsy radiation thera... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission | NCT00522301 | Fallopian Tube ... Ovarian Cancer Primary Periton... | sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... pharmacological... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission | NCT00522301 | Fallopian Tube ... Ovarian Cancer Primary Periton... | sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... pharmacological... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy | NCT00897299 | Breast Cancer Estrogen Recept... Her-2 Pgr | microarray anal... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer | NCT01009983 | Breast Cancer Recurrent Breas... Stage IV Breast... | panitumumab paclitaxel carboplatin laboratory biom... immunohistochem... | 18 Years - | Wake Forest University Health Sciences | |
| Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy | NCT01194635 | Head and Neck C... | fluorescence in... gene expression... polymerase chai... protein analysi... protein express... enzyme-linked i... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | NCT00176527 | Prostate Cancer | recombinant int... docetaxel estramustine ph... isotretinoin polyacrylamide ... protein express... immunohistochem... | 18 Years - | Rutgers, The State University of New Jersey | |
| 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx | NCT00757549 | Head and Neck C... | cetuximab cisplatin TdT-mediated dU... 3'-deoxy-3'-[18... immunohistochem... laboratory biom... fludeoxyglucose... radiation thera... | 18 Years - 120 Years | Mayo Clinic | |
| Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer | NCT00080860 | Breast Cancer | microarray anal... immunohistochem... conventional su... lymphangiograph... radionuclide im... sentinel lymph ... technetium Tc 9... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | NCT00640081 | Colorectal Canc... | cetuximab capecitabine fluorouracil leucovorin calc... oxaliplatin immunohistochem... laboratory biom... | 18 Years - 100 Years | Medical Research Council | |
| Assessment of Candidate Protein Expression in Breast Cancer Specimens | NCT00918892 | Breast Cancer | gene expression... immunohistochem... laboratory biom... | - | Case Comprehensive Cancer Center | |
| Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate | NCT01582009 | Clear Cell Rena... Recurrent Renal... Stage III Renal... Stage IV Renal ... | panobinostat everolimus laboratory biom... pharmacological... liquid chromato... mass spectromet... enzyme-linked i... immunohistochem... | 18 Years - | Roswell Park Cancer Institute | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer | NCT00379509 | Breast Cancer | lapatinib ditos... TdT-mediated dU... gene expression... microarray anal... immunohistochem... biopsy radiation thera... | 18 Years - 120 Years | UNC Lineberger Comprehensive Cancer Center | |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
| Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery | NCT01292083 | Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Triple-negative... | azacitidine laboratory biom... immunohistochem... polymerase chai... western blottin... nucleic acid se... therapeutic con... | 18 Years - | University of Southern California | |
| Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | NCT00873275 | Colorectal Canc... | bevacizumab FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin ursodiol RNA analysis gene expression... polymerase chai... western blottin... immunohistochem... laboratory biom... pharmacological... positron emissi... | 18 Years - | City of Hope Medical Center | |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma | NCT00822848 | Sarcoma | epirubicin hydr... ifosfamide sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... neoadjuvant the... therapeutic con... hypofractionate... | 15 Years - 120 Years | OHSU Knight Cancer Institute | |
| Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma | NCT01366157 | Lymphoma | microarray anal... protein express... immunohistochem... laboratory biom... | - 21 Years | Children's Oncology Group | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab | NCT01150643 | Lymphoma | gene expression... microarray anal... polymerase chai... polymorphism an... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer. | NCT00611715 | Breast Cancer | erlotinib hydro... letrozole fluorescence in... immunohistochem... laboratory biom... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery | NCT01234935 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem... | 18 Years - | Translational Oncology Research International | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma | NCT01387724 | Neuroblastoma | RNA analysis polymerase chai... protein express... proteomic profi... western blottin... enzyme-linked i... immunohistochem... laboratory biom... liquid chromato... mass spectromet... | 1 Year - 10 Years | Children's Oncology Group | |
| Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer | NCT01118039 | Bladder Cancer Transitional Ce... Urethral Cancer | sunitinib malat... immunohistochem... laboratory biom... pharmacological... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer | NCT00898664 | Head and Neck C... | cytogenetic ana... gene expression... mutation analys... polymerase chai... immunohistochem... laboratory biom... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone Marrow | NCT00824538 | Breast Cancer | sunitinib malat... flow cytometry immunohistochem... laboratory biom... | 18 Years - 120 Years | University of California, San Francisco | |
| Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma | NCT01339663 | Recurrent Melan... Stage IV Melano... | cyclophosphamid... aldesleukin autologous tumo... laboratory biom... immunologic tec... immunohistochem... polymerase chai... therapeutic aut... | 18 Years - | Fred Hutchinson Cancer Center | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia | NCT00005619 | Leukemia | polymerase chai... flow cytometry immunohistochem... | 18 Years - | Northwestern University | |
| Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer | NCT00082979 | Breast Cancer | cytogenetic ana... proteomic profi... cytology specim... immunohistochem... laboratory biom... breast duct lav... | 18 Years - 64 Years | National Cancer Institute (NCI) | |
| Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer | NCT00019201 | Head and Neck C... Lung Cancer | cytology specim... immunohistochem... sputum cytology bronchoscopic a... bronchoscopy comparison of s... endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | NCT00989105 | Prostate Cancer | immunohistochem... laboratory biom... pharmacological... computed tomogr... magnetic resona... single photon e... technetium Tc 9... | 18 Years - | Cancer Research UK | |
| Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma | NCT01239875 | Cutaneous B-cel... Extranodal Marg... Nodal Marginal ... Adult Diffuse M... Adult Diffuse S... Adult Grade III... Adult Immunobla... Adult Lymphobla... Grade 1 Follicu... Grade 2 Follicu... Grade 3 Follicu... Mantle Cell Lym... Marginal Zone L... Small Lymphocyt... Splenic Margina... Waldenstrom Mac... | dendritic cell ... cryotherapy pneumococcal po... laboratory biom... immunoenzyme te... immunohistochem... autologous dend... | 18 Years - 90 Years | Mayo Clinic | |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
| EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer | NCT00049140 | Head and Neck C... | EF5 bioluminescence flow cytometry immunohistochem... biopsy | 18 Years - | Duke University | |
| Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma | NCT00049010 | Melanoma (Skin) | comparative gen... cytogenetic ana... fluorescence in... immunohistochem... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Laboratory-Treated T Cells and Aldesleukin After Cyclophosphamide in Treating Patients With Stage IV Melanoma | NCT00553306 | Recurrent Melan... Stage IV Melano... | therapeutic aut... aldesleukin cyclophosphamid... biopsy immunohistochem... flow cytometry polymerase chai... | 18 Years - 75 Years | Fred Hutchinson Cancer Center | |
| AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer | NCT00415298 | Head and Neck C... | DACH polymer pl... oxaliplatin gene expression... immunohistochem... pharmacological... biopsy | 18 Years - | National Cancer Institute (NCI) | |
| Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | NCT00388089 | Lung Cancer Unspecified Adu... | bortezomib topotecan hydro... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | University of California, Davis | |
| Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma | NCT00736450 | Contiguous Stag... Noncontiguous S... Stage I Adult D... Stage III Adult... Stage IV Adult ... | oblimersen sodi... rituximab cyclophosphamid... doxorubicin hyd... vincristine sul... prednisone biopsy microarray anal... immunohistochem... gene expression... cytogenetic ana... | 19 Years - | University of Nebraska | |
| Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma | NCT01239875 | Cutaneous B-cel... Extranodal Marg... Nodal Marginal ... Adult Diffuse M... Adult Diffuse S... Adult Grade III... Adult Immunobla... Adult Lymphobla... Grade 1 Follicu... Grade 2 Follicu... Grade 3 Follicu... Mantle Cell Lym... Marginal Zone L... Small Lymphocyt... Splenic Margina... Waldenstrom Mac... | dendritic cell ... cryotherapy pneumococcal po... laboratory biom... immunoenzyme te... immunohistochem... autologous dend... | 18 Years - 90 Years | Mayo Clinic | |
| Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT00499655 | Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | erlotinib hydro... celecoxib placebo laboratory biom... immunohistochem... fluorescence in... mutation analys... protein express... gene expression... | 18 Years - | City of Hope Medical Center | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer | NCT00049140 | Head and Neck C... | EF5 bioluminescence flow cytometry immunohistochem... biopsy | 18 Years - | Duke University | |
| Studying Gene Expression in Samples From Younger Patients With Neuroblastoma | NCT01553448 | Neoplastic Synd... Neuroblastoma | gene expression... protein express... enzyme-linked i... immunohistochem... laboratory biom... medical chart r... | - 21 Years | Children's Oncology Group | |
| Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment | NCT00538291 | Colorectal Canc... | cetuximab capecitabine gene expression... microarray anal... polymorphism an... reverse transcr... immunohistochem... | 18 Years - | City of Hope Medical Center | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | NCT00369109 | Breast Cancer Colorectal Canc... Pancreatic Canc... | biologic sample... immunohistochem... laboratory biom... biopsy | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803 | NCT00897351 | Prostate Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer | NCT00305669 | Prostate Cancer | sargramostim immunohistochem... immunological d... laboratory biom... conventional su... neoadjuvant the... | - | University of California, San Francisco | |
| Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma | NCT01365962 | Sarcoma | gene expression... immunohistochem... laboratory biom... mass spectromet... | - | Children's Oncology Group | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers | NCT00900419 | Esophageal Canc... Head and Neck C... Lung Cancer Precancerous Co... | immunohistochem... laboratory biom... sputum cytology biopsy | 21 Years - 90 Years | University of Colorado, Denver | |
| Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck | NCT00720304 | Head and Neck C... | docetaxel erlotinib hydro... fluorescence in... polymerase chai... immunoenzyme te... immunohistochem... laboratory biom... pharmacological... therapeutic con... intensity-modul... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
| EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | NCT00041028 | Lung Cancer | EF5 flow cytometry immunohistochem... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Proteins in Head and Neck Cancer Cells | NCT00896948 | Head and Neck C... | Southern blotti... TdT-mediated dU... gene expression... protein express... flow cytometry fluorescent ant... immunoenzyme te... immunohistochem... immunologic tec... | - 120 Years | Vanderbilt University Medical Center | |
| Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab | NCT01150643 | Lymphoma | gene expression... microarray anal... polymerase chai... polymorphism an... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx | NCT00498953 | Head and Neck C... | carboplatin cisplatin docetaxel fluorouracil lapatinib ditos... cytogenetic ana... fluorescence in... in situ hybridi... polymerase chai... reverse transcr... immunohistochem... laboratory biom... conventional su... neoadjuvant the... fludeoxyglucose... radiation thera... | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors | NCT00985868 | Unspecified Chi... | multikinase inh... enzyme-linked i... immunohistochem... laboratory biom... pharmacological... | 2 Years - 18 Years | Cancer Research UK | |
| Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer | NCT00770185 | Endometrial Can... | ridaforolimus gene expression... immunohistochem... laboratory biom... | 18 Years - | Canadian Cancer Trials Group | |
| Dasatinib in Treating Patients With Stage IV Pancreatic Cancer | NCT00544908 | Pancreatic Canc... | dasatinib immunoenzyme te... immunohistochem... laboratory biom... quality-of-life... | 18 Years - | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
